[Balancing between hope and hype in biomarker research]

Patrick M M Bossuyt1

  • 1Academisch Medisch Centrum/Universiteit van Amsterdam, afd. Klinische Epidemiologie, Biostatistiek en Bioinformatica, Amsterdam, the Netherlands. p.m.bossuyt@amc.uva.nl

Summary

Biomarker research is expanding, but many studies lack rigorous methods, particularly in patient group selection. This limits the translation of potential biomarkers into clinical practice due to inconsistent findings.